Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Wein

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Medicinal Chemistry|July 24, 2025
Development of an RXR Agonist Scaffold with Pronounced Homodimer PreferenceFelix Nawa, Arthur Kardanov, Till Kasch, et al.
Toxicology Letters|November 4, 2017
Searching for putative binding sites of the bispyridinium compound MB327 in the nicotinic acetylcholine receptorThomas Wein, Georg Höfner, Sebastian Rappenglück, et al.
RSC Medicinal Chemistry|September 8, 2025
Tailored SirReal-type inhibitors enhance SIRT2 inhibition through ligand stabilization and disruption of NAD<sup>+</sup> co-factor bindingRicky Wirawan, Matthias Frei, Anna Heider, et al.
Organic & Biomolecular Chemistry|September 29, 2022
Self-reporting styrylthiazolium photopharmaceuticals: mitochondrial localisation as well as SAR drive biological activityLi Gao, Yvonne Kraus, Andrea Stegner, et al.
Journal of Medicinal Chemistry|September 26, 2023
Structure-Guided Design of Nurr1 Agonists Derived from the Natural Ligand DihydroxyindoleMinh Sai, Jan Vietor, Moritz Kornmayer, et al.
Chemmedchem|October 27, 2018
Synthesis of a Series of Non-Symmetric Bispyridinium and Related Compounds and Their Affinity Characterization at the Nicotinic Acetylcholine ReceptorSebastian Rappenglück, Sonja Sichler, Georg Höfner, et al.
Chemmedchem|July 6, 2018
Synthesis of a Series of Structurally Diverse MB327 Derivatives and Their Affinity Characterization at the Nicotinic Acetylcholine ReceptorSebastian Rappenglück, Sonja Sichler, Georg Höfner, et al.
Journal of Medicinal Chemistry|September 11, 2024
Tuning RXR Modulators for PGC1α RecruitmentFelix Nawa, Minh Sai, Jan Vietor, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Medicinal Chemistry|July 24, 2025
Development of an RXR Agonist Scaffold with Pronounced Homodimer PreferenceFelix Nawa, Arthur Kardanov, Till Kasch, et al.
Toxicology Letters|November 4, 2017
Searching for putative binding sites of the bispyridinium compound MB327 in the nicotinic acetylcholine receptorThomas Wein, Georg Höfner, Sebastian Rappenglück, et al.
RSC Medicinal Chemistry|September 8, 2025
Tailored SirReal-type inhibitors enhance SIRT2 inhibition through ligand stabilization and disruption of NAD<sup>+</sup> co-factor bindingRicky Wirawan, Matthias Frei, Anna Heider, et al.
Organic & Biomolecular Chemistry|September 29, 2022
Self-reporting styrylthiazolium photopharmaceuticals: mitochondrial localisation as well as SAR drive biological activityLi Gao, Yvonne Kraus, Andrea Stegner, et al.
Journal of Medicinal Chemistry|September 26, 2023
Structure-Guided Design of Nurr1 Agonists Derived from the Natural Ligand DihydroxyindoleMinh Sai, Jan Vietor, Moritz Kornmayer, et al.
Chemmedchem|October 27, 2018
Synthesis of a Series of Non-Symmetric Bispyridinium and Related Compounds and Their Affinity Characterization at the Nicotinic Acetylcholine ReceptorSebastian Rappenglück, Sonja Sichler, Georg Höfner, et al.
Chemmedchem|July 6, 2018
Synthesis of a Series of Structurally Diverse MB327 Derivatives and Their Affinity Characterization at the Nicotinic Acetylcholine ReceptorSebastian Rappenglück, Sonja Sichler, Georg Höfner, et al.
Journal of Medicinal Chemistry|September 11, 2024
Tuning RXR Modulators for PGC1α RecruitmentFelix Nawa, Minh Sai, Jan Vietor, et al.
Pageof 3